KAI Logo (White)
 

Are you an innovator?

Find out how KAI could help you transform your brand market approach and grow.

Sign Up For
Our Newsletter

By subscribing to our newsletter, you agree to the use of your personal data in accordance with KAI Conversations Privacy Policy.

  • Home
  • About
  • Become a Partner
  • Resources
  • Contact
  • Terms & Conditions
  • Privacy Policy
KAI Logo
LinkedIn Logo (White)
X Logo (White)

© 2026 KAI Conversations Ltd.

KAI Logo

© 2026 KAI Conversations Ltd.

  • Home
  • About
  • Become a Partner
  • Resources
  • Contact
  • Terms & Conditions
  • Privacy Policy
Sign Up For
Our Newsletter

By subscribing to our newsletter, you agree to the use of your personal data in accordance with KAI Conversations Privacy Policy.

LinkedIn Logo (White)
X Logo (White)
 

Top 5 Global Pharma optimises Medical Liaison Interactions pre and post new respiratory launch

November 27, 2025
1 min read

Challenge

Top 5 Global Pharma Company launching new respiratory drug.

MSL team deployed to capture early market feedback from Key opinion leaders and build relationships.

Desire to improve conversational capability with external interactions by addressing strengths and areas of development.

Approach

KAI used to analyse pre-launch role-plays.

Effectiveness of delivery and quality of engagement evaluated with individual feedback for each MSL. Post launch KAI analysed live conversations to review improvements in delivery. Timely feedback given on customer insights on attitudes and beliefs to the treatment area and specific drug messages.

Quotes

The AI analysis and coaching program is a key plank in helping us to transform the medical function from educational to KOL engagement.”

SVP Medical Affairs

+600%

Creating Clarity

Results

MSL’s time spent on recycling and packing insight was halved due to automation with KAI. HCP engagement increased due to each individual empowered with personalised feedback. 

200% increase in questioning of more than one topic and 600% increase in creating clarity. Project started in the US now being rolled out across all treatment areas and across all main global markets.